IO Biotech CEO Mai-Britt Zocca's 2021 pay jumps 1,892% to $8.2M
IO Biotech reports 2021 executive compensation
By ExecPay News
Published: April 14, 2022
IO Biotech reported fiscal year 2021 executive compensation information on April 14, 2022.
In 2021, three IO Biotech executives received on average a compensation package of $4.5M, a 950% increase compared to previous year.
Average pay of disclosed executives at IO Biotech
Mai-Britt Zocca, Chief Executive Officer, received $8.2M in total, which increased by 1,892% compared to 2020. 94% of Zocca's compensation, or $7.6M, was in option awards. Zocca also received $115K in non-equity incentive plan and $399K in salary.
Eva Ehrnrooth, Chief Medical Officer, received a compensation package of $2.7M, which increased by 501% compared to previous year. 84% of the compensation package, or $2.3M, was in option awards.
Muhammad Al-Hajj, Chief Scientific Officer, earned $2.7M in 2021.
Related executives
You may also like
Source: SEC filing on April 14, 2022.